A carregar...
Bevacizumab in Glaucoma: Where do We Stand?
The use of antivascular endothelial growth factors such as bevacizumab and ranibizumab has brought about a revolution in management protocols of various ophthalmic disorders. A lot has been written about these agents, still lacunae exist in our understanding due to paucity of randomized control tria...
Na minha lista:
| Publicado no: | J Curr Glaucoma Pract |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Jaypee Brothers Medical Publishers
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161771/ https://ncbi.nlm.nih.gov/pubmed/28028350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10008-1110 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|